T2 Biosystems, Inc. Stock price
Is T2 Biosystems, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,120 stocks worldwide.
Key metrics
T2 Biosystems, Inc. Stock Analysis
Analyst Opinions
6 Analysts have issued a T2 Biosystems, Inc. forecast:
Analyst Opinions
6 Analysts have issued a T2 Biosystems, Inc. forecast:
Don't miss a Thing! We will send you all news about T2 Biosystems, Inc. directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology, which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types. It products include T2Bacteria Panel, T2Candida Panel, T2Dx Instrument, AND T2MR Technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.
| Head office | United States |
| CEO | Mr. Jalbert |
| Employees | 113 |
| Founded | 2006 |
| Website | www.t2biosystems.com |


